Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-05

Clinical Trial Update: Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two antiviral treatments for recurrent herpes labialis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Padagis LLC | Conditions: Herpes Labialis | Phase 3 | Status: COMPLETED | Results posted: 2021-01-05